These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 7996063

  • 1. Infusional cisplatin and etoposide in the treatment of stage III-B and IV non-small cell lung cancer: a well tolerated regimen.
    Glynn P, Higby D, Moriarty E, Ficalora M, Volpe B, Koletsky A, White C.
    J Med; 1994; 25(3-4):193-201. PubMed ID: 7996063
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD, Greco FA.
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [Abstract] [Full Text] [Related]

  • 3. Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer.
    Breathnach OS, Georgiadis MS, Schuler BS, Pizzella P, Llorens V, Kasturi V, Steinberg SM, O'Neil K, Takimoto CH, Johnson BE.
    Clin Cancer Res; 2000 Jul; 6(7):2670-6. PubMed ID: 10914708
    [Abstract] [Full Text] [Related]

  • 4. Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188.
    Lokich J, Auerbach M, Essig L, Fryer J, Fryer D.
    J Infus Chemother; 1995 Jul; 5(2):70-2. PubMed ID: 8521238
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
    Figlin RA, Crowley JJ, Jacobs EL, Muirhead M, Goodwin JW, Rinehart JJ, Livingston RB.
    Cancer; 1996 Sep 01; 78(5):998-1003. PubMed ID: 8780537
    [Abstract] [Full Text] [Related]

  • 6. Pilot study of ambulatory infusional delivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide.
    Lokich J, Anderson N, Moore C, Bern M, Coco F, Dow E, Zipoli T, Gonzalves L.
    J Infus Chemother; 1996 Sep 01; 6(1):43-6. PubMed ID: 8748007
    [Abstract] [Full Text] [Related]

  • 7. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L, LeChevalier T, Gottfried M, Adams D, Ruffie P, LeCesne A, Tete L, Pellae-Cosset B.
    Semin Oncol; 1995 Dec 01; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [Abstract] [Full Text] [Related]

  • 8. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM, Lynch TJ, Elias AD, Jacobs C, Herbst R, Leong T, Lynch C, Kwiatkowski DJ, Carey RW, Grossbard ML, Skarin AT.
    Semin Oncol; 1997 Aug 01; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [Abstract] [Full Text] [Related]

  • 9. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ, Fernandes AL, Pereira JR, Curtis JR, Santoro IL.
    Lung Cancer; 2006 Aug 01; 53(2):171-6. PubMed ID: 16757059
    [Abstract] [Full Text] [Related]

  • 10. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P.
    Semin Oncol; 2000 Feb 01; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [Abstract] [Full Text] [Related]

  • 11. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA, Drinkard LC, Hoffman PC, Lane N, Watson S, Samuels BL, Bitran JD, Golomb HM, Vokes EE.
    Cancer J Sci Am; 1995 Feb 01; 1(4):288-94. PubMed ID: 9166490
    [Abstract] [Full Text] [Related]

  • 12. Cisplatin, etoposide, and vincristine combination chemotherapy in the treatment of non-small cell lung cancer.
    Watanabe A, Ichiyama S, Shimokata K, Nagura E, Saito H, Saka H, Nomura F, Sakai S, Saito H.
    Nagoya J Med Sci; 1993 Mar 01; 55(1-4):41-6. PubMed ID: 8247105
    [Abstract] [Full Text] [Related]

  • 13. Chemoradiotherapy for poor-risk stage III non-small cell lung cancer.
    Lau DH, Ryu JK, Gandara DR.
    Semin Oncol; 1997 Aug 01; 24(4 Suppl 12):S12-110-S12-112. PubMed ID: 9331133
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V, Galetta D, Lorusso V, Caruso M, Verderame F, Pezzella G, Borsellino N, Durini E, Valenza R, Agostara B, Colucci G, Gruppo Oncologico Italia Meridionale.
    Lung Cancer; 2008 Sep 01; 61(3):369-77. PubMed ID: 18308419
    [Abstract] [Full Text] [Related]

  • 15. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M, Chapman R, Kim JH.
    Cancer J Sci Am; 1996 Sep 01; 2(6):314-20. PubMed ID: 9166551
    [Abstract] [Full Text] [Related]

  • 16. Individualized chemotherapy for patients with non-small cell lung cancer determined by prospective identification of neuroendocrine markers and in vitro drug sensitivity testing.
    Shaw GL, Gazdar AF, Phelps R, Linnoila RI, Ihde DC, Johnson BE, Oie HK, Pass HI, Steinberg SM, Ghosh BC.
    Cancer Res; 1993 Nov 01; 53(21):5181-7. PubMed ID: 8221655
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Comparative study of 2 doses of cisplatin combined with etoposide in the treatment of non-small cell carcinoma of the lung].
    Farris A, Cadau ML, Ortu R, Contu A, Piga M, Sarobba MG, Schena GP, Ginesu F.
    G Ital Chemioter; 1986 Nov 01; 33(2-3):157-60. PubMed ID: 2824271
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.